ERBB2 and triple-negative breast carcinoma: According to the expression condition of biomarkers, there are threetypes: hormone-receptor-positive human epidermal growth receptor2 (Her-2)-positive or triple-negative breast cancer (TNBC) (known asTNBCs, defined by the lack of ER, PR, and Her-2) which contains 15% ofthe whole breast cancer population [38].